The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Enhanced activity of a hydrogen sulphide‐releasing derivative of mesalamine (ATB‐429) in a mouse model of colitis
Open accessAbstract
Background and Purpose: Mesalamine is the first‐line therapy for colitis, but it lacks potency and is only effective for mild‐to‐moderate forms of this disease. Hydrogen sulphide has been shown to be a potent, endogenous anti‐inflammatory substance, modulating leukocyte‐endothelial adhesion and leukocyte migration. The purpose of this study was to determine if an H 2 S‐releasing derivative of mesalamine (ATB‐429) would exhibit increased potency and effectiveness in a mouse model of colitis. Experimental Approach: Colitis was induced in mice with trinitrobenzene sulphonic acid and the effects of ATB‐429 and mesalamine were compared in several treatment regimens. The severity of colitis was determined using several indices, including a disease activity score (comprised of scores for diarrhea, weight loss and fecal blood), colonic myeloperoxidase activity and macroscopic/microscopic scoring of tissue injury. Key Results: Irrespective of the treatment regiment, ATB‐429 was more effective than mesalamine in reducing the severity of colitis. ATB‐429 was particularly effective in reducing granulocyte infiltration into the colonic tissue (by ∼70%), as well as reducing the expression of mRNA for several key proinflammatory cytokines/chemokines (e.g., TNF α, IFN γ). Treatment with ADT‐OH, the H 2 S‐releasing moiety of ATB‐429, did not affect severity of colitis. Conclusions and Implications: ATB‐429 exhibits a marked increase in anti‐inflammatory activity and potency in a murine model of colitis, as compared to mesalamine. These results are consistent with recently described anti‐inflammatory effects of H 2 S. ATB‐429 may represent an attractive alternative to mesalamine for the treatment of inflammatory bowel disease. British Journal of Pharmacology (2007) 150, 996–1002. doi:10.1038/sj.bjp.0707193
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wallace, J. L., Caliendo, G., Santagada, V., Cirino, G., & Fiorucci, S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.042 · Cited by 271
Self-citationDistrutti, E., Sediari, L., Mencarelli, A., Renga, B., Orlandi, S., Russo, G., Caliendo, G., Santagada, V., Cirino, G., Wallace, J. L., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106435 · Cited by 144
Self-citation
Cited by
Hydrogen Sulfide and Cell Signaling
Li, L., Rose, P., & Moore, P. K. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100505 · Cited by 1,296
A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications
Powell, C. R., Dillon, K. M., & Matson, J. B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.11.014 · Cited by 599
Hydrogen sulfide as a gasotransmitter
Gadalla, M. M., & Snyder, S. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06580.x · Cited by 498
Szabo, C., & Papapetropoulos, A. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.014050 · Cited by 423
Yang, R., Qu, C., Zhou, Y., Konkel, J. E., Shi, S., Liu, Y., Chen, C., Liu, S., Liu, D., Chen, Y., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.017 · Cited by 390
Metadata
- Authors
- Fiorucci, S., Orlandi, S., Mencarelli, A., Caliendo, G., Santagada, V, Distrutti, E., Santucci, L., Cirino, G., & Wallace, J. L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-04
- Volume
- 150
- Issue
- 8
- Pages
- 996-1002
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1888068317
- Cited by
- 214
- References
- 2
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced activity of a hydrogen sulphide‐releasing derivative of mesalamine (ATB‐429) in a mouse model of colitis. https://app.cochat.ai/papers/10.1038/sj.bjp.0707193
- The paper
- Fiorucci, S., Orlandi, S., Mencarelli, A., Caliendo, G., Santagada, V, Distrutti, E., Santucci, L., Cirino, G., & Wallace, J. L. (2007). Enhanced activity of a hydrogen sulphide‐releasing derivative of mesalamine (ATB‐429) in a mouse model of colitis. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0707193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.